EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polyamine Pathway Inhibitor DENSPM Suppresses Lipid Metabolism in Pheochromocytoma Cell Line

Hans K Ghayee, Kaylie A Costa, Yiling Xu, Heather M Hatch iD, Mateo Rodriguez, Shelby C Straight, Marian Bustamante, Fahong Yu iD, Fatima Smagulova iD, John A Bowden, Sergei G Tevosian

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hans K Ghayee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, College of Medicine, University of Florida and Malcom Randall VA Medical Center, Gainesville, FL 3…. Hauptthemen laut MEDLINE: Pheochromocytoma, Lipid Metabolism, Polyamines, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NATL INST OF HLTH NCATS, SDHB PHEO PARA COALITION.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pheochromocytomas (PCCs) are tumors arising from chromaffin cells in the adrenal medulla, and paragangliomas (PGLs) are tumors derived from extra-adrenal sympathetic or parasympathetic paraganglia; these tumors are collectively referred to as PPGL cancer. Treatment for PPGL primarily involves surgical removal of the tumor, and only limited options are available for treatment of the disease once it becomes metastatic. Human carriers of the heterozygous mutations in the succinate dehydrogenase subunit B (SDHB) gene are susceptible to the development of PPGL. A physiologically relevant PCC patient-derived cell line hPheo1 was developed, and SDHB_KD cells carrying a stable short hairpin knockdown of SDHB were derived from it. An untargeted metabolomic approach uncovered an overactive polyamine pathway in the SDHB_KD cells that was subsequently fully validated in a large set of human SDHB-mutant PPGL tumor samples. We previously reported that treatment with the polyamine metabolism inhibitor N1,N11-diethylnorspermine (DENSPM) drastically inhibited growth of these PCC-derived cells in culture as well as in xenograft mouse models. Here we explored the mechanisms underlying DENSPM action in hPheo1 and SDHB_KD cells. Specifically, by performing an RNAseq analysis, we have identified gene expression changes associated with DENSPM treatment that broadly interfere with all aspects of lipid metabolism, including fatty acid (FA) synthesis, desaturation, and import/uptake. Furthermore, by performing an untargeted lipidomic liquid chromatography–mass spectrometry (LC/MS)-based analysis we uncovered specific groups of lipids that are dramatically reduced as a result of DENSPM treatment. Specifically, the bulk of plasmanyl ether lipid species that have been recently reported as the major determinants of cancer cell fate are notably decreased. In summary, this work suggests an intersection between active polyamine and lipid pathways in PCC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaLipid MetabolismPolyaminesAdrenal Gland NeoplasmsHumansCell Line, TumorSuccinate DehydrogenasePiperidinesAnimalsMiceGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DENSPMSDHBparagangliomapheochromocytomaplasmanyl

Substanzen

PolyaminesSuccinate DehydrogenaseSDHB protein, humanPiperidines

Autor:innen und Institutionen

  • Department of Medicine, Division of Endocrinology, College of Medicine, University of Florida and Malcom Randall VA Medical Center, Gainesville, FL 32608, USA.
  • Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 03610, USA.
  • The Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL 32610, USA.
  • Université de Rennes, EHESP, Inserm, Irset (Institut de Recherche en Santé, Environnement et Travail), Campus Sante de Villejean-UMR_S 1085, F-35000 Rennes, France.

ORCID-Profile: Heather M Hatch, Fahong Yu, Fatima Smagulova

Förderung

  • NCATS NIH HHS
  • NATL INST OF HLTH NCATS
  • SDHB PHEO PARA COALITION

Zitieren

APA

Ghayee, H. K., Costa, K. A., Xu, Y., Hatch, H. M., Rodriguez, M., Straight, S. C., Bustamante, M., Yu, F., Smagulova, F., Bowden, J. A., & Tevosian, S. G. (2024). Polyamine Pathway Inhibitor DENSPM Suppresses Lipid Metabolism in Pheochromocytoma Cell Line. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810029

Vancouver

Ghayee HK, Costa KA, Xu Y, Hatch HM, Rodriguez M, Straight SC, et al. Polyamine Pathway Inhibitor DENSPM Suppresses Lipid Metabolism in Pheochromocytoma Cell Line. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810029

BibTeX
@article{Ghayee2024,
  author = {Ghayee, Hans K and Costa, Kaylie A and Xu, Yiling and Hatch, Heather M and Rodriguez, Mateo and Straight, Shelby C and Bustamante, Marian and Yu, Fahong and Smagulova, Fatima and Bowden, John A and Tevosian, Sergei G},
  title = {Polyamine Pathway Inhibitor DENSPM Suppresses Lipid Metabolism in Pheochromocytoma Cell Line},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810029}
}
Kostenlos starten →